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E chocardiography is a versatile, accurate, and readily available method for the evalu- ation of cardiac anatomy and function. 
Used in conjunction with exercise or pharmaco- 
logic stress protocols, modern 2-dimensional 
echocardiographic techniques can readily assess 
regional as well as global left ventricular (LV) 
function, and provide information regarding the 
presence, severity, and distribution of coronary 
artery disease. Infusion of the P-receptor agonist 
dobutamine to pharmacologically induce cardiovas- 
cular “stress” in conjunction with cchocardio- 
graphy is a practical method for the evaluation of 
cardiac function and the diagnosis of coronary 
artery disease when the patient is unable to excr- 
cise to adequate levels of cardiovascular stress. In 
addition to the diagnosis of coronary artery dis- 
ease, preliminary studies suggest that dobutamine 
stress echocardiography can provide prognostic 
information following acute myocardial infarction 
and an indication of tissue viability for myocardium 
that is dysfunctional at rest following an acute 
ischemic event or aborted infarction. 
WALL MOTION ANALYSIS 
LV function can be readily assessed using 2-di- 
mensional cchocardiography. Utilizing standard 
parasternal and apical windows, the left ventricle 
can be imaged and its walls divided into segments 
for regional wall motion analysis and assessment of 
global function. The myocardium is conventionally 
divided into basal, midcavitary, and apical thirds. 
Circumferentially, the walls arc divided into ante- 
rior, lateral, posterior, inferior, inferoseptal, and 
anteroseptal regions. Functional analysis of re- 
gional wall motion is used to identify areas as 
normal, hypokinetic, akinetic, or dyskinetic. In 
addition, myocardium that is full-thickness is differ- 
entiated from that which is thinned, scarred, and 
aneurysmal. A wall motion score can be generated 
by combining the scores of individual regions, 
providing an indication of overall LV function. In 
addition, the percentage of normally functioning 
myocardium can be calculated, providing a quanti- 
tative measure of the amount of myocardium that 
is dysfunctional. 
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ECHOCARDIOGRAPHY AND MY-W 
ISCHEMIA 
Surface 2-dimensional echocardiography has 
been used to assess the location and extent of acute 
myocardial infarction, as well as to identify patients 
at high risk following myocardial infarction. This 
has been possible due to the ability of 2-dimen- 
sional echocardiography to identify areas of myocar- 
dium with abnormal systolic function despite nor- 
mal wall thickness. The fundamental premise of 
cchocardiographic wall motion analysis is that 
ischcmia or acute infarction results in an abnormal 
mechanical function of a portion of the left ventri- 
cle, which is detected as myocardium that is of 
normal thickness in diastole but that fails to demon- 
strate normal systolic thickening. The echocardio- 
graphic differentiation of myocardium that is isch- 
emit from that which is recently infarcted is made 
by monitoring for subsequent functional recovery 
of that region. Recovery would be suggestive of 
transient ischemia or stunning, whereas permanent 
regional dysfunction with subsequent thinning and 
formation of scar is consistent with myocardial 
infarction and necrosis. 
EXERCISE ECHOCARDIOGRAPHY 
The ability to dctcct regional wall dysfunction 
has made 2-dimensional echocardiography a useful 
adjunct to exercise testing for the diagnosis of 
coronary artery disease. In 1983, Limacher et al’ 
published data on the use of echocardiography in 
conjunction with exercise testing in 73 patients. 
The sensitivity for detecting coronary artery dis- 
case based on an abnormal ejection fraction re- 
sponse or the development of regional wall dyssyn- 
ergia was 91%, with a specificity of 88%. Berberich 
et al2 published data in 1984 with similar sensitivity 
and specificity results (94% for each parameter) 
for the detection of coronary artcry disease using 
immediate postcxercise echocardiography. Com- 
pared with clcctrocardiographic (ECG) monitor- 
ing alone during exercise testing, an improvement 
in accuracy as well as a reduction in nondiagnostic 
tests with the use of echocardiography was de- 
scribed in 1 series published by Armstrong et al in 
1986”. In this series, 35 of 44 patients (80%) with 
normal resting wall motion on echocardiography 
and significant coronary artcry disease on angiogra- 
phy were identified using exercise echocardio- 
graphy, compared with only 19 (43%) identified 
using ECG criteria alone. Among those patients 
without significant coronary artery disease, 13 of 15 
(87%) were correctly diagnosed with exercise 
echocardiography, compared with only 8 (53%) 
with ECG, and 18 ambiguous exercise ECG results 
could be reclassified as diagnostic studies by utiliz- 
ing echocardiographic wall motion analysis. 
The sensitivity and specificity of exercise 
echocardiography for the diagnosis of coronary 
artery disease was further evaluated in 123 patients 
by Armstrong et al in 1987.4 The sensitivity and 
specificity for the detection of coronary artery 
disease were 100% and 72%, respectively, for 
patients with single-vessel disease, and 97% and 
86%, respectively, for patients with multivessel 
disease. In this series, exercise echocardiography 
correctly identified 32 of 59 patients (54%) as 
having multivcssel disease. False-negative exercise 
echocardiograms were obtained in 12 patients 
(10%) 8 of whom had single-vessel coronary artery 
disease. 
In a series published by Ryan et al” in 1988, the 
sensitivity and specificity of exercise echocardio- 
graphy among 64 patients with normal resting wall 
motion were found to be 78% and lOO%, rcspec- 
tively. False-negative studies were found only 
among patients with single-vessel disease, and the 
sensitivity of exercise cchocardiography for the 
detection of single-vessel disease was found to be 
superior to that of ECG monitoring alone. 
The prognostic value of a normal exercise 
echocardiogram was described by Sawada et al in 
1990.6 Among 148 patients with normal exercise 
echocardiograms who were followed for a mean of 
28 months, only 6 subsequent cardiac events were 
noted. All 6 events occurred in patients who 
achieved <6 METS or < 85% of their predicted 
maximal heart rate with exercise. This confirms 
that a normal exercise cchocardiogram in a patient 
with good exercise capacity predicts an excellent 
prognosis with respect to subsequent cardiac events. 
NONEXERCISE STRESS ECHOCARDIOGRAPHY 
The inability of a patient to exercise and achieve 
an adequate heart rate and blood pressure re- 
sponse is a major limitation to exercise stress 
protocols for the diagnosis of coronary artery 
disease. Physical limitations to exercise may exist 
secondary to lung disease, peripheral vascular 
disease, disorders of the central nervous system, or 
poor general physical conditioning. In order to 
circumvent the physical limitations of some pa- 
ticnts, noninvasive techniques have been devel- 
oped to provide an assessment for coronary artcry 
disease without the use of exercise. 
Several protocols for noncxercise stress testing 
in conjunction with echocardiographic wall motion 
analysis have been described. These include the 
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use of static stress modalities such as cold pressor, 
hand grip, atria1 pacing and mental stress, and 
pharmacologic stress testing including vasodilators 
such as adenosinc and dipyridamole. Inotropic 
agents such as isoproterenol, dopaminc, and dobu- 
tamine have also been used for this purpose. 
Dipyridamole echocardiography was first de- 
scribed by Picano et al in 1985.7 Utilizing the 
maximal coronary vasodilating effect of dipyri- 
damolc on the normal coronary vasculature, re- 
gions of myocardial flow inhomogcneity can be 
provoked in the presence of a coronary stenosis. 
The coronary flow mismatch is sufficient in some 
casts to induce a wall motion abnormality that can 
subsequently bc detected on echocardiography. 
Using this as a marker, the sensitivity of dipyri- 
damole echocardiography for the detection of 
coronary artery disease has been reported to be 
53-88%, with greater sensitivity in the presence of 
multivessel disease and in patients with regional 
areas of resting myocardial dyssynergia.x 
DOBUTAMINE STRESS ECHDCABDIDGRAPHY 
Dobutamine is a pi receptor agonist that exerts 
positive inotropic activity without significant cx or 
p2 effects.” This results in little effect on peripheral 
vascular tone and considerably less chronotropic 
and arrhythmogenic activity than dopamine, nore- 
pinephrine, or isoprotercnol. It was demonstrated 
as early as 1976 that dobutamine exerts a differen- 
tial effect on the perfusion of myocardium supplied 
by stenotic, as compared with normal, coronary 
arterieslO In patients without coronary artery dis- 
ease, dobutamine resulted in a greatly increased 
coronary arterial perfusion, whereas in patients 
with significant coronary stenoses, dobutaminc in- 
fusion resulted in an inhomogeneous pattern of 
coronary perfusion. As was subsequently described 
by Fung et al, ” dobutamine is an effective agent for 
precipitating myocardial dysfunction and is there- 
fore well suited for use in stress protocols that rely 
on the functional assessment of myocardial perfor- 
mance. 
Dobutaminc stress echocardiography incorpo- 
rates the USC of 2-dimensional echocardiographic 
wall motion analysis in the baseline state and 
during incremental stages of intravenous dobu- 
tamine infusion. Specific protocols vary with rc- 
spect to precise dosage range and the timing of 
interval stages. One such protocol involves the use 
of four 3-minute stages of dobutamine infusion, at 
doses of 5, 10,20, and 30 pg/kg/min. Heart rate is 
continuously monitored, and blood pressure and 
an ECG are recorded at the end of each 3-minute 
stage. Infusion may bc terminated before protocol 
completion in the event an ischemic response is 
seen on 2-dimensional cchocardiography or in the 
event of significant ST-segment depression. 
Echocardiographic images are obtained at base- 
line and at the completion of each stage. Using 
modern electronic equipment, echocardiographic 
images obtained at baseline, at 5 pg/kg/min, at 
peak infusion, and at 5 minutes postinfusion are 
digitized for display in quad-screen format. Wall 
motion analysis can be performed with side-by-side 
comparison of each stage in all echocardiographic 
views. 
The normal echocardiographic pattern of LV 
wall motion during dobutamine infusion is hyperdy- 
namic myocardial contractility, sometimes result- 
ing in near obliteration of the LV cavity during 
peak infusion. Depicted in Figure 1 is an example 
of end-diastolic and end-systolic frames from the 
parastcrnal long axis view of a normal patient at 
baseline and during peak dobutamine infusion of 
30 kg/kg/min. Myocardial ischemia during dobu- 
tamine infusion is visualized echocardiographically 
as the induction of a regional wall motion abnormal- 
ity in a coronary arterial perfusion bed. Figure 2 
depicts end-diastolic and end-systolic frames from 
a dobutamine stress echocardiogram in a patient 
with an occluded left circumflex coronary artery. In 
this example, the posterior wall becomes akinetic 
at peak dobutamine infusion. 
In 1986, Bet-the et all2 described the use of 
echocardiographic wall motion analysis during dob- 
utamine infusion to assess for multivessel coronary 
artery disease in patients following acute myocar- 
dial infarction. In this series of 30 patients, dobu- 
tamine stress echocardiography correctly identified 
11 of 13 patients with multivessel disease, and 15 of 
17 patients without coronary disease remote from 
the area of infarction, yielding a sensitivity and 
specificity of 85% and 88%, respectively, for identi- 
fication of patients with multivcssel disease. In 
1988, Manncring et al” studied dobutamine stress 
echocardiography in 50 patients following myocar- 
dial infarction. They described a high level of 
concordance of results between the dobutamine 
stress echocardiogram and standard cxcrcise tread- 
mill ECG testing. 
Several preliminary studies have been reported 
describing the use of dobutamine stress echocardio- 
graphy for the detection of coronary artery disease. 
Mazeika et alI4 presented a series of 46 patients 
with suspected coronary artery disease and found a 
sensitivity of 63% and a specificity of 93%. For 
patients with 3-vessel disease, the sensitivity in this 
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series was 77%. Marcovitz et all5 described the use 
of dobutamine stress echocardiography in patients 
with complex coronary anatomy. In this study of 44 
patients, there was an overall sensitivity and speci- 
ficity for the detection of coronary artery disease of 
97% and 45%, respectively. Specificity was ad- 
versely affected by the presence of an underlying 
cardiomyopathy or a resting wall motion abnormal- 
ity following coronary intervention, with 4 of 6 
false-positive dobutamine stress echocardiograms 
occurring in 1 of these 2 clinical settings. 
In 1991, Sawada et all6 published data from a 
larger series on dobutamine stress echocardio- 
graphy for the detection of coronary artery disease. 
In this study of 103 patients, dobutamine stress 
echocardiography was used to assess the presence 
of coronary artery disease both in patients with 
normal wall motion at rest and for the presence of 
remote coronary disease in patients with a resting 
wall motion abnormality. Among 55 patients with 
normal resting wall motion, dobutamine stress 
echocardiography correctly identified 31 of 35 
patients with coronary artery disease (89% sensitiv- 
ity) and 17 of 20 patients with no significant 
coronary artery disease (85% specificity). Speci- 
ficity was 100% for the 14 patients with multivessel 
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disease, and 81% for those with single-vessel dis- 
ease. Among 48 patients with abnormal LV wall 
motion at rest, dobutamine stress echocardio- 
graphy correctly identified 21 of 26 patients with 
remote coronary artery disease (81% sensitivity), 
and 13 of 15 patients without distant disease (87% 
specificity). 
Dobutamine stress echocardiography has been 
used for the assessment of risk following myocar- 
dial infarction. In data published in abstract form 
by Sawada in 1990, an abnormal dobutamine stress 
echocardiogram was found to be a sensitive predic- 
tor of future cardiac events.” Among 28 patients 
followed for the development of unstable angina, 
congestive heart failure, or death for an average of 
6.9 months after myocardial infarction, 8 of 9 
morbid events occurred in the 17 patients who had 
a dobutaminc stress cchocardiogram positive for a 
new wall motion abnormality consistent with induc- 
ible ischemia. Only 1 event occurred among the 11 
patients with a negative dobutamine stress cchocar- 
diogram. 
ECHDCARDIDGRAPW AND THRDMBDLYSIS 
The use of thrombolytic agents has made a 
marked impact on the subsequent morbidity and 
mortality following myocardial infarction. The prog- 
nosis of the patient and the risk for the develop- 
ment of adverse cardiac events following thrombo- 
lytic use during acute myocardial infarction is 
largely dependent on the size of the infarction and 
the presence of residually ischemic or jeopardized 
myocardium. Surface 2-dimensional echocardio- 
graphy is uniquely suited to evaluate the location 
and extent of the initial infarction and the degree 
of functional recovery, as well as assess for the 
presence of myocardium that remains ischemic 
versus that which is viable and at risk of reinfarc- 
tion after thrombolytic therapy. 
Echocardiography has been used to describe an 
improvement in LV wall motion following reperfu- 
sion during acute myocardial infarction. In 1988, 
Presti et al’” described 16 patients treated with 
angioplasty during acute anterior wall myocardial 
infarction. Early treatment was associated with a 
subsequent improvement in echocardiographic wall 
motion score. Bourdillon ct ali9 described a rapid 
improvement in LV wall motion following repcrfu- 
sion, seen as early as 1 day and usually maximal at 3 
days following reperfusion therapy for acute myo- 
cardial infarction. Broderick et al*” demonstrated 
that regional assessment of LV function by 2-dimen- 
sional echocardiography after reperfusion was su- 
perior to assessment of global function by ejection 
fraction. 
Data from the Thrombolysis in Myocardial In- 
farction (TIMI) group*’ have reinforced the need 
to base any interventional procedures following 
thrombolysis on the presence of recurrent isch- 
emia, as there appears to be no reduction in 
morbidity or mortality associated with routine 
catheterization and angioplasty. On the other hand, 
the noninvasive evaluation of the presence of 
inducible ischemia following thrombolytic therapy 
is problematic: Exercise testing without the use of a 
concomitant imaging modality is confounded by 
the evolving ST-segment shifts found after acute 
myocardial infarction, and reports of the use of 
exercise or dipyridamole “stress” thallium-201 scin- 
tigraphy have been associated with poor sensitivity 
and specificity for both residual stenoses in the 
infarct-related artery and for the detection of 
multivessel disease.22-24 
Dobutamine4str8ssechocarcEographyin~ 
emia fobwing thmnbolyds: Limited experience 
has been reported with the use of dobutamine 
stress echocardiography in the evaluation of pa- 
tients following thrombolytic therapy for acute 
myocardial infarction. Although the high sensitiv- 
ity of dobutamine stress echocardiography for the 
detection of residual stenoses is retained, there is 
an apparent reduction in the specificity of the test 
following acute coronary intervention. Preliminary 
data from 3 series have been presented on the use 
of dobutamine stress echocardiography following 
acute intervention during myocardial infarction. 
The data previously cited by Marcovitz et all5 
demonstrated a high sensitivity but low specificity 
for the detection of residual stenoses following 
coronary intervention. Richards et al*” reviewed 
the results of dobutamine stress echocardiography 
performed 5-7 days after thrombolytic therapy for 
acute myocardial infarction in 21 patients who had 
undergone quantitative coronary arteriography. 
Wall motion abnormalities were induced in 9 of 10 
regions with significant stenoses in the territory of 
the infarct-related artery, and in 4 of 7 regions 
corresponding to stenoses in the distribution of 
noninfarct-related arteries. However, in patients 
without significant residual stenoses, wall motion 
abnormalities were inducible in 9 of 11 territories 
corresponding to the infarct-related artcry and in 
21 of 44 territories distinct from the infarct-related 
artery. As was previously noted, thallium-201 scin- 
tigraphy in these patients had a poor specificity 
that was nearly identical to that of echocardio- 
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graphy for the detection of significant coronary 
obstruction. 
In another series published in abstract form, 
Smart et alz5 described the use of dobutamine 
stress echocardiography in the assessment of multi- 
vessel disease or the presence of significant resid- 
ual stenosis in the infarct-related artery following 
thrombolytic therapy. A total of 52 patients were 
studied, 26 of whom had multivessel disease. In 
this study, the positive and negative predictive 
values of the dobutamine stress echocardiogram 
for the presence of multivessel disease were 76% 
and 74%, respectively. The prediction of residual 
stenosis in the infarct-related artery was found to 
be dependent on the presence of viable myocar- 
dium in the infarct zone. 
D~ERMINAllON OF VIADIUTY 
Myocardial stunning following a prolonged isch- 
emit insult is a well-described phenomenon and 
can be seen after reperfusion therapy.26 Although 
the stunned myocardium is viable, there is a 
persistent wall motion abnormality early after the 
ischemic event which eventually improves follow- 
ing reperfusion. In addition to assessing for signifi- 
cant residual stenosis in the infarct-related artery 
and screening for multivessel disease, the manage- 
ment of patients following thrombolytic therapy 
necessitates establishing the viability of myocar- 
dium in regions with persistent wall motion abnor- 
malities. 
There is a physiologic basis for the use of 
dobutamine stress echocardiography for the assess- 
ment of tissue viability after an ischemic insult. In 
1984, Ellis et a127 described the use of 2-dimen- 
sional echocardiography during a low-dose dobu- 
tamine infusion (5-10 vg/kg/min) in an open- 
chest dog model with myocardium salvaged by 
reperfusion. In this setting, dobutamine infusion 
resulted in a significant increase in systolic wall 
thickening in the reperfusion zone both 1 hour and 
24 hours after reperfusion. In another study, isopro- 
terenol infusion was studied using technetium-99m 
angiography 2 weeks after streptokinase administra- 
tion for myocardial infarction and the results 
correlated with vessel patency.28 Although resting 
ejection fractions were identical irrespective of 
vessel patency, there was a significantly greater 
increase in LV ejection fraction in those patients 
with a patent infarct-related artery compared with 
those with persistent occlusion. 
These studies provide evidence that, at low 
doses, inotropic stimulation with P-receptor ago- 
nists will result in an increase in LV function in 
areas of viable myocardium but not in areas of 
myocardial necrosis. Dobutamine stress echocardio- 
graphy, with a graduated infusion of the p-receptor 
agonist dobutamine, is well-suited to provide func- 
tional information at incremental levels of ino- 
tropic stimulation. The differential response at low 
doses, of dobutamine infusion can be used to 
distinguish viable (but dysfunctional) from necrotic 
myocardium and establish tissue viability. 
Data supporting the use of dobutamine stress 
echocardiography for the determination of viability 
of dysfunctional myocardium following reperfusion 
in humans come from 2 studies. In 1 study pub- 
lished in 1990, Pierard et a129 compared metabolic 
data from positron emission tomography (PET) 
and functional response data from early dobu- 
tamine stress echocardiography with subsequent 
wall motion recovery in 17 patients treated with 
thrombolytic therapy for acute myocardial infarc- 
tion. In the 5 patients in this study with evidence of 
tissue glucose metabolism and intact myocardial 
perfusion on PET scanning, an improvement in 
regional wall thickening on dobutamine stress 
echocardiography was noted. All 5 had functional 
recovery on subsequent examination. Of the 6 
patients with no evidence of tissue glucose metabo- 
lism on PET, none had a significant improvement 
in wall motion on either early dobutamine stress 
echocardiography or on later functional evalua- 
tion. Analyzing these data for the predictive value 
of the early dobutamine stress echocardiogram, 
none of the 7 patients lacking evidence of myocar- 
dial viability on early dobutamine stress echocardio- 
graphy demonstrated any functional recovery on 
subsequent evaluation. Of the patients with evi- 
dence of myocardial viability on early dobutamine 
stress echocardiography, 7 of 10 (70%) had subse- 
quent functional recovery. Of the 3 patients who 
did not have later improvement in wall motion, all 
had early PET analysis positive for glucose metab- 
olism, indicative of tissue viability. 
Smart and colleagues30 published a study in 
abstract form that similarly addresses functional 
recovery of myocardium .in 33 patients following 
thrombolytic therapy for acute infarction. In this 
study, 10 of 15 patients (67%) with improvement of 
regional wall motion at low doses of dobutamine 
infusion had subsequent functional recovery. Of 18 
patients without evidence of improvement in wall 
motion on low dose dobutamine infusion, 14 (78%) 
had no functional improvement on subsequent 
examination. 
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coNcLlJsloN 
Dobutamine stress cchocardiography is a practi- 
cal method for the noninvasive assessment for 
significant coronary artery disease in patients phys- 
ically unable to exercise. In the absence of a 
baseline myopathy or prior coronary intervention, 
it is a sensitive and specific test for the detection of 
coronary artery discasc. 
Experience is being gained in using dobutaminc 
stress echocardiography as a tool to establish 
prognosis after myocardial infarction. In addition, 
dobutamine stress echocardiography appears to be 
a promising tcchniquc for the assessment of tissue 
viability for myocardium that remains dysfunc- 
tional following repcrfusion therapy during acute 
myocardial infarction. 
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